Xvivo Perfusion AB (publ) (LON:0RKL)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	477	474	1,112	810	435	671
Market Cap Growth	-51.47%	-57.38%	37.21%	86.41%	-35.22%	-16.57%
Enterprise Value	464	461	1,081	766	410	648
Last Close Price	15.18	14.89	35.29	25.72	14.78	22.75
PE Ratio	235.31	233.59	89.46	113.04	296.26	1007.78
PS Ratio	7.29	7.24	18.73	17.37	13.15	31.80
PB Ratio	2.80	2.78	7.14	5.34	3.82	6.39
P/TBV Ratio	4.05	4.01	10.81	7.84	6.86	10.06
P/FCF Ratio	-	58.16	379.77	3172.09	564.50	-
P/OCF Ratio	58.59	58.16	138.41	224.23	195.98	-
EV/Sales Ratio	6.95	7.05	18.21	16.42	12.40	30.71
EV/EBITDA Ratio	40.73	41.32	135.06	515.41	387.15	-
EV/EBIT Ratio	63.83	64.75	167.53	1818.08	1156.32	-
EV/FCF Ratio	-	56.62	369.29	2998.27	532.54	-
Debt / Equity Ratio	0.06	0.06	0.02	0.02	0.01	0.00
Debt / EBITDA Ratio	0.90	0.90	0.28	1.06	0.51	-
Debt / FCF Ratio	1.23	1.23	0.84	9.61	1.03	-
Net Debt / Equity Ratio	-0.08	-0.08	-0.18	-0.26	-0.16	-0.31
Net Debt / EBITDA Ratio	-1.21	-1.21	-3.44	-27.04	-17.78	33.59
Net Debt / FCF Ratio	-1.66	-1.66	-9.41	-157.29	-24.46	17.66
Asset Turnover	0.34	0.34	0.36	0.30	0.25	0.19
Inventory Turnover	0.89	0.89	1.12	1.23	1.29	1.02
Quick Ratio	3.68	3.68	3.14	4.94	2.60	4.43
Current Ratio	5.77	5.77	4.58	6.15	3.47	5.24
Return on Equity (ROE)	1.18%	1.18%	8.39%	5.44%	1.36%	0.71%
Return on Assets (ROA)	2.31%	2.31%	2.43%	0.17%	0.17%	-0.87%
Return on Invested Capital (ROIC)	2.97%	3.10%	4.80%	0.40%	0.35%	-2.41%
Return on Capital Employed (ROCE)	3.90%	3.90%	4.00%	0.30%	0.30%	-1.30%
Earnings Yield	0.42%	0.43%	1.12%	0.89%	0.34%	0.10%
FCF Yield	-	1.72%	0.26%	0.03%	0.18%	-0.27%
Buyback Yield / Dilution	0.29%	0.29%	-5.73%	-1.39%	-2.04%	-6.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.